Plus Therapeutics (PSTV) Change in Cash (2010 - 2026)
Plus Therapeutics (PSTV) reported Change in Cash of -$5.7 million for Q1 2026, down 158.58% year-over-year from $9.8 million in Q1 2025, and down 26.59% quarter-over-quarter from -$4.5 million in Q4 2025.
Plus Therapeutics (PSTV) Change in Cash (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 17 years of Change in Cash data on file, last reported at -$5.7 million in Q1 2026.
- Change in Cash for Q1 2026 came in at -$5.7 million, down 158.58% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.8 million (down 198.26% YoY), and the FY2025 annual result was $8.7 million, up 202.41% from the prior year.
- Change in Cash retreated to -$5.7 million in Q1 2026 per PSTV's latest filing, from -$4.5 million in the prior quarter.
- Over five years, Change in Cash peaked at $11.1 million in Q3 2025 and troughed at -$7.6 million in Q2 2025.
- A 5-year average of -$904588.2 and a median of -$2.1 million in 2022 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2024 and 2025: Change in Cash sank 3423.42% in 2024, then jumped 399.7% in 2025.
- A 5-year view of Change in Cash shows it stood at -$2.1 million in 2022, then fell by 14.26% to -$2.5 million in 2023, then jumped by 53.22% to -$1.1 million in 2024, then plunged by 295.03% to -$4.5 million in 2025, then dropped by 26.59% to -$5.7 million in 2026.
- Business Quant data shows PSTV's Change in Cash at -$5.7 million in Q1 2026, -$4.5 million in Q4 2025, and $11.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -45.97 Mn |
| 10 | Plus Therapeutics | 34.26 Mn | 19.15 Mn | - | -5.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.74 Mn |
| Dec 31, 2025 | -4.53 Mn |
| Sep 30, 2025 | 11.06 Mn |
| Jun 30, 2025 | -7.63 Mn |
| Mar 31, 2025 | 9.79 Mn |
| Dec 31, 2024 | -1.15 Mn |
| Sep 30, 2024 | -3.69 Mn |
| Jun 30, 2024 | 2.01 Mn |
| Mar 31, 2024 | -5.65 Mn |
| Dec 31, 2023 | -2.45 Mn |
| Sep 30, 2023 | 111,000.00 |
| Jun 30, 2023 | -1.83 Mn |
| Mar 31, 2023 | -5.40 Mn |
| Dec 31, 2022 | -2.15 Mn |
| Sep 30, 2022 | 2.18 Mn |
| Jun 30, 2022 | -3.15 Mn |
| Mar 31, 2022 | 2.84 Mn |
| Dec 31, 2021 | -2.88 Mn |
| Sep 30, 2021 | 4.12 Mn |
| Jun 30, 2021 | 2.71 Mn |